Prospective Follow-up of Patients With Glycogen Storage Disease Type III
- Disease/Condition
- Neuromuscular Disorders
- Drug/Device/Intervention
- Different motor function tests
- Study type
- Interventional
- Intervention type
- procedure
- Primary sponsor
- Institut de Myologie, France
- Location
- Paris, France
- Phase
- N/A
- Start date
- Feb 01, 2011
- End date
- Aug 01, 2016
- Enrollment
- 30 participants
Knee flexion and extension strength,Knee flexion and extension strength,Knee flexion and extension strength,Time to perform each motor function test,Time to perform each motor function test,Time to perform each motor function test,Gait speed measured during the 6 minutes walk test,Gait speed measured during the 6 minutes walk test,Gait speed measured during the 6 minutes walk test
The aim of this study is to improve knowledge of natural history and methods of monitoring
 the evolution of Glycogen storage disease type III regarding the muscle and to study the
 prospective approach of large series of patients, and using the same protocol for the follow
 up of the children and adults.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT01563705
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT01563705 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut de Myologie, France and is currently status unknown. The study focuses on Neuromuscular Disorders. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.